Andrew Revell

811 total citations
20 papers, 468 citations indexed

About

Andrew Revell is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Andrew Revell has authored 20 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in Andrew Revell's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers) and HIV/AIDS Research and Interventions (13 papers). Andrew Revell is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers) and HIV/AIDS Research and Interventions (13 papers). Andrew Revell collaborates with scholars based in United Kingdom, Canada and United States. Andrew Revell's co-authors include Keith Wesnes, David M. Warburton, Brendan Larder, Richard Harrigan, Clifford Lane, Sean Emery, Dechao Wang, Maurizio Zazzi, Maria Jesús Pérez‐Elías and Antonella d’Arminio Monforte and has published in prestigious journals such as Psychopharmacology, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Andrew Revell

19 papers receiving 450 citations

Peers

Countries citing papers authored by Andrew Revell

Since Specialization

Citations

This map shows the geographic impact of Andrew Revell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Revell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Revell more than expected).

Fields of papers citing papers by Andrew Revell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Revell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Revell. The network helps show where Andrew Revell may publish in the future.

Co-authorship network of co-authors of Andrew Revell

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Revell. A scholar is included among the top collaborators of Andrew Revell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Revell. Andrew Revell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response 2019 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Andrew Revell, Dechao Wang, Maria Jesús Pérez‐Elías, Robin Wood, Hugo Tempelman, Bonaventura Clotet, Peter Reiss, Ard I. van Sighem, Gerardo Alvarez‐Uria, Mark Nelson, Julio Montaner, H. Clifford Lane, Brendan Larder, (unknown)	0
2	An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype 2016 ·Journal of Antimicrobial Chemotherapy ·Andrew Revell, Dechao Wang, Robin Wood, Carl Morrow, Hugo Tempelman, Raph L Hamers, Peter Reiss, Ard I. van Sighem, Mark Nelson, Joan Montaner, H. Clifford Lane, Brendan Larder	6
3	Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa 2016 ·Southern African Journal of HIV Medicine ·Andrew Revell, (unknown), (unknown), Sean Emery, Dechao Wang, Robin Wood, Carl Morrow, Hugo Tempelman, Raph L Hamers, Peter Reiss, Ard van Sighem, Anton Pozniak, Julio Montaner, H. Clifford Lane, Brendan Larder	5
4	Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa 2016 ·Southern African Journal of HIV Medicine ·Andrew Revell, (unknown), (unknown), Sean Emery, Dechao Wang, Robin Wood, Carl Morrow, Hugo Tempelman, Raph L Hamers, Peter Reiss, Ard van Sighem, Anton Pozniak, Julio Montaner, H. Clifford Lane, Brendan Larder	1
5	Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings 2013 ·Antiviral Therapy ·(unknown), Andrew Revell, (unknown), Raph L Hamers, (unknown), Roos E. Barth, Annemarie M. J. Wensing, Casey D. Morrow, Robin Wood, (unknown), Peter Reiss, M Nelson, Sean Emery, Julio Montaner, H. C. Lane	1
6	Potential Impact of a Free Online HIV Treatment Response Prediction System for Reducing Virological Failures and Drug Costs after Antiretroviral Therapy Failure in a Resource-Limited Setting 2013 ·BioMed Research International ·Andrew Revell, Gerardo Alvarez‐Uria, (unknown), Anton Pozniak, Julio Montaner, H. Clifford Lane, Brendan Larder	5
7	The use of computational models to predict response to HIV therapy for clinical cases in Romania 2012 ·GERMS ·Andrew Revell, Luminiţa Ene, Dan Duiculescu, (unknown), Mike Youle, Anton Pozniak, Julio Montaner, Brendan Larder	10
8	Computational models that predict response to HIV therapy can reduce virological failure and therapy costs in resource‐limited settings 2012 ·Journal of the International AIDS Society ·Andrew Revell, (unknown), Gerardo Alvarez‐Uria, Adrian Streinu‐Cercel, Luminiţa Ene, Amj Wensing, Raph L Hamers, Carl Morrow, Robin Wood, (unknown), (unknown), Mark Nelson, Julio Montaner, H. Clifford Lane, (unknown), (unknown)	2
9	Clinical Evaluation of the Potential Utility of Computational Modeling as an HIV Treatment Selection Tool by Physicians with Considerable HIV Experience 2011 ·AIDS Patient Care and STDs ·Brendan Larder, Andrew Revell, JoAnn M. Mican, Brian K. Agan, Marianne Harris, Carlo Torti, Ilaria Izzo, Julia A. Metcalf, (unknown), Vincent C. Marconi, Dechao Wang, Dan Coe, Brian Gazzard, Julio Montaner, H. Clifford Lane	16
10	The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool 2011 ·AIDS ·Andrew Revell, Dechao Wang, Mark Boyd, Sean Emery, Anton Pozniak, (unknown), Richard Harrigan, Julio Montaner, Clifford Lane, Brendan Larder	20
11	Modelling response to antiretroviral therapy without a genotype as a clinical tool for resource-limited settings 2011 ·Data Archiving and Networked Services (DANS) ·Brendan Larder, Andrew Revell, (unknown), Raph L Hamers, (unknown), Roos E. Barth, Amj Wensing, Carl Morrow, Robin Wood, (unknown), Rolf Kaiser, Anton Pozniak, H. Clifford Lane, Julio Montaner	1
12	Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings 2010 ·Journal of Antimicrobial Chemotherapy ·Andrew Revell, (unknown), Richard Harrigan, Raph L Hamers, Amj Wensing, (unknown), Mark Nelson, Anna María Geretti, Brendan Larder	23
13	A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 2009 ·Artificial Intelligence in Medicine ·Dechao Wang, Brendan Larder, Andrew Revell, Julio Montaner, Richard Harrigan, (unknown), Joep M. A. Lange, Scott A. Wegner, Lidia Ruíz, Maria Jesús Pérez‐Elías, Sean Emery, José M. Gatell, Antonella d’Arminio Monforte, Carlo Torti, Maurizio Zazzi, Clifford Lane	49
14	Computational models developed without a genotype for resource-poor countries predict response to HIV treatment with 82% accuracy 2009 ·Data Archiving and Networked Services (DANS) ·Andrew Revell, (unknown), Richard Harrigan, (unknown), Lı́dia Ruiz, Sean Emery, Maria Jesús Pérez‐Elías, Carlo Torti, John D. Baxter, (unknown), Brian Gazzard, Anna María Geretti, Schlomo Staszewski, Raph L Hamers, A. M. J. Wensing, J Lange, Julio Montaner, (unknown)	3
15	The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy 2007 ·Antiviral Therapy ·Brendan Larder, Dechao Wang, Andrew Revell, Joan Montaner, Richard Harrigan, (unknown), Joep M. A. Lange, Scott A. Wegner, Lidia Ruíz, Maria Jesús Pérez‐Elías, Sean Emery, José M. Gatell, Antonella d’Arminio Monforte, Carlo Torti, Maurizio Zazzi, Clifford Lane	59
16	Smokers of the future 1991 ·British Journal of Addiction ·David M. Warburton, Andrew Revell, (unknown)	40
17	Smoking and performance — a puff-by-puff analysis 1988 ·Psychopharmacology ·Andrew Revell	42
18	Smoking as a coping strategy 1985 ·Addictive Behaviors ·Andrew Revell, David M. Warburton, Keith Wesnes	58
19	Smoking and academic performance 1984 ·Current Psychology ·David M. Warburton, Keith Wesnes, Andrew Revell	7
20	The separate and combined effects of scopolamine and nicotine on human information processing 1984 ·Psychopharmacology ·Keith Wesnes, Andrew Revell	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact